NTA provides a curated pipeline of vetted opportunities aligned with industry and national priorities. We are continuously consolidating new opportunities from Catalyst Partners, government requirements, and industry targets. Contact us to share your opportunities with NTA’s diverse community or organizations. Join NTA today to receive email notifications.
Upcoming
Consolidated Nerve Agent Treatment System
Anticipated Release Date: Q3FY26 FDA approval of a multi-drug autoinjector to reduce logistical burden on the warfighter and increase survivability …
Threat Agnostic Host Directed MCMs
Anticipated Release Date: Q2 FY27 Next-generation CBRN resilience initiative aimed at delivering threat agnostic host directed medical countermeasures that enhance …
Medical Decontamination Personnel Skin
Anticipated Release Date: Q4 2027 This opportunity requires membership in the Medical CBRN Defense Consortium (MCDC). This Consortium releases numerous …
Advanced Differential Diagnostics (ADD)
Anticipated Release Date: Q4 FY27 Host response based test to predict illness severity. Responding to this opportunity requires membership in …
Advanced Differential Diagnostics (ADD)
Anticipated Release: Q4FY27 Host response based test to predict illness severity. Responding to this opportunity requires membership in the Countering …
Active
DoW Prostate Cancer, Idea Development Award
Due: September 2, 2026 The fiscal year 2026 (FY26) Prostate Cancer Research Program (PCRP) Idea Development Award (IDA) supports new …
DoW Lung Cancer Idea Development Award
Due: September 2, 2026 The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Idea Development Award (IDA) supports conceptually …
Novel Mechanism Research on Neuropsychiatric Symptoms in Alzheimer’s Dementia
Due: September 7, 2026 The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will …
Assay Development and Screening for Discovery of Chemical Probes, Drugs or Immunomodulators
Due: September 7, 2026 Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification …
Alcohol Treatment, Pharmacotherapy, and Recovery Research
Due: September 7, 2026 The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required …
Research Projects to Enhance Applicability of Mammalian Models for Translational Research
Due: September 7, 2026 Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects …
Schizophrenia and Related Disorders During Mid- to Late Life
Due: September 7, 2026 Although the majority living with schizophrenia and related disorders are over 35 years old, including those …
Cellular and Molecular Biology of Complex Brain Disorders
Due: September 7, 2026 This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated …
Grant Opportunity: Research Projects to Enhance Applicability of Mammalian Models for Translational Research
DUE: September 7, 2026 The National Cancer Institute invites applications for projects to expand, improve, or transform the utility of …
Grant Opportunity: Assay development and screening for discovery of chemical probes, drugs or immunomodulators
DUE: September 7, 2026 Seeking applications for identification of small molecules that function to elucidate the biology of disease as …
Expansion of Domestic Manufacturing Capacity for Nitrile Gloves
Due: September 8, 2026 ASPR IBMSC is seeking to expand the domestic manufacturing capacity of nitrile gloves. This capacity expansion …
Sustainment of PPE Capacities – Nitrile Butadiene Rubber
Due: September 8, 2026 ASPR IBMSC is seeking to support production capacity for nitrile butadiene rubber (NBR) in support of …
DoW Hearing Restoration Focused Research Award
Due: September 10, 2026 The fiscal year 2026 (FY26) Hearing Restoration Research Program (HRRP) Focused Research Award (FRA) supports promising …
Vendor Managed Inventory Capabilities for APIs Used in Medical Countermeasure FDF Drug Products
Due: September 14, 2026 ASPR IBMSC is seeking to establish vendor managed inventory (VMI) capabilities for active pharmaceutical ingredients (APIs) …
NSF Dynamic Language Infrastructure – NEH Documenting Endangered Languages
Due: September 15, 2026 This funding partnership between the National Science Foundation (NSF) and the National Endowment for the Humanities …
Probability Program
Due: September 15, 2026 The Probability Program supports research on the theory and applications of probability. Subfields include discrete probability, …
DoW Reconstructive Transplant, Concept Award
Due: September 16, 2026 The fiscal year 2026 (FY26) Reconstructive Transplant Research Program (RTRP) Concept Award supports the exploration of …
DoW Duchenne Muscular Dystrophy, Idea Development Award
Due: September 18, 2026 The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Idea Development Award (IDA) promotes …
DoW Duchenne Muscular Dystrophy, Clinical/Translational Research Award
Due: September 18, 2026 The fiscal year 2026 (FY26) Duchenne Muscular Dystrophy Research Program (DMDRP) Clinical/Translational Research Award (CTRA) supports …
DoW Neurofibromatosis Exploration-Hypothesis Development Award
Due: September 22, 2026 The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Exploration-Hypothesis Development Award (EHDA) supports the initial …
DoW Neurofibromatosis Research Academy Scholar Award
Due: September 22, 2026 The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy’s Scholar Award (NFRA-SA) supports …
DoW Alzheimer’s Transforming Care Award
Due: September 24, 2026 The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Care Award (TrCA) supports clinical research …
DoW Alzheimer’s Transforming Diagnosis Award
Due: September 24, 2026 The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Diagnosis Award (TrDA) supports non-incremental, solutions-oriented …
DoW Alzheimer’s Transforming Research Award
Due: September 24, 2026 The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, …
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026
Due: September 25, 2026 Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites applications for P50 Research …
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System
Due: September 28, 2026 The purpose of this announcement is to encourage investigators to pursue a small clinical trial to …
DoW Kidney Cancer, Idea Development Award
Due: September 28, 2026 The fiscal year 2026 (FY26) Kidney Cancer Research Program (KCRP) Idea Development Award (IDA) supports the …
Windows on the Universe: The Era of Multi-Messenger Astrophysics
Due: September 30, 2026 The Universe is the ultimate laboratory, and we can now probe it as never before through …
DoW Rare Cancers Concept Award
Due: September 30, 2026 The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Concept Award (CA) supports highly innovative, …
Biological Technologies
Due: September 30, 2026 The Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office (BTO) is soliciting proposals that leverage …
DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
Due: September 30, 2026 The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports …
Long Range Broad Agency Announcement for Navy and Marine Corps Science and Technology
Due: September 30, 2026 ONR, ONRG, and MCWL are interested in receiving proposals for Long-Range S&T Projects that offer potential …
DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award
Due: September 30, 2026 The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award …
DoW Breast Cancer, Breakthrough Award Level 3
Due: September 30, 2026 The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research …
Broad Request for Solutions
Due: September 30, 2026 The purpose of this broad request for solutions is to solicit innovative proposals for prototype development, …
EDU Core Research
Due: October 1, 2026 The EDU Core Research (ECR) program offers this ECR:Core solicitation and invites proposals for fundamental research …
In Vivo High-Resolution Imaging for Inner Ear Visualization
Due: October 1, 2026 This funding opportunity aims to support the development of in vivo high-resolution structural and functional imaging …
DoW, Ovarian Cancer, Ovarian Cancer Clinical Trial Academy Early-Career Investigator Award
Due: October 1, 2026 Created in FY23, the Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career …
DoW, Ovarian Cancer, Pilot Award
Due: October 1, 2026 The Ovarian Cancer Pilot Award supports research that expands or modifies current thinking about and/or approaches …
DoW, Ovarian Cancer, Investigator-Initiated Research Award
Due: October 1, 2026 The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award is intended to support high-impact research that …
Cooperative Agreement for In Vivo High-Resolution Imaging for Inner Ear Visualization
Due: October 1, 2026 This funding opportunity aims to support high risk clinical trials for the development of in vivo …
Grant Opportunity: Personal Health Informatics for Delivering Actionable Insights to Individuals
DUE: November 5, 2026 Furthering the science of personal health informatics by providing meaningful and actionable insights to individuals through …
TechConnect Critical Technology Spotlights
Due: November 18, 2026 The TechConnect Critical Technology Spotlights are an open innovation program focused on accelerating breakthrough technologies in …
Grant Opportunity: Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics
DUE: January 7, 2027 Funding available to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics …
Grant Opportunity: Improving Diagnostic Safety in Ambulatory Care
DUE: August 31, 2028 Funding opportunity to develop strategies and interventions to improve diagnostic safety in the heterogenous ambulatory care …
AHRQ Health Services Research Projects
Due: October 6, 2029 The purpose of this Notice of Funding Opportunity (NOFO) is to seek health services research grant …